BUZZ-Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus

Radiopharm Theranostics RAD.AX leaps as much as 50% to A$0.036; set for biggest ever intraday pct gain

Biopharma secures private placement agreement with Massachusetts-based Lantheus Holdings LNTH.O to raise $5 mln

Issue price of A$0.060 represents 150% premium to last close

Co earlier signed co-development deal with the NASDAQ-listed firm to develop biopharmaceuticals in Australia

Stock hits its highest level since Dec. 10, 2024

More than 12.9 mln shares traded, 1.2x the 30-day avg

RAD fell 67.6% in 2024 - third consecutive bear run since 2022

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com;))